펩톤 시장 규모 조사 및 예측 : 원료별, 용도별, 형태별, 제품별 및 지역별 예측(2026-2036년)

Global Peptone Market Definition & Scope

The Global Peptone Market, valued at USD 300.00 million in 2025, is anticipated to reach USD 522.10 million by 2036, expanding at a 5.1% CAGR during the forecast period. Peptones are hydrolysates of proteins containing amino acids, peptides, vitamins and growth promoting nutrients and are used as essential components of culture media for microbiological, cell culture, pharmaceutical manufactures, biotechnology processes, food fermentation and industrial microbiology. They are enzymatically or acid-hydrolysed from animal, plant or microbial sources and are of crucial importance for the support of microbial growth and bioprocess efficiency. The market is steadily growing due to increasing biopharmaceutical production, increasing vaccine development, rising demand for cell culture media and increasing biotechnology research activities. Ongoing investments in vaccine manufacturing, biologics, and advanced therapeutics are driving global demand for high-quality cell culture ingredients, according to the World Health Organisation (WHO, 2024). Continuous innovation in recombinant proteins, microbial fermentation and bioprocess optimisation continues to drive long-term market growth.

Global Peptone Market: Key Highlights

• The Global Peptone Market is expected to reach USD 522.10 million by 2036, growing at a CAGR of 5.1% during the forecast period (2025-2036), from USD 300.00 million in 2025.
• The market is dominated by North America, owing to the advanced biopharmaceutical industry, extensive biotechnology research, and large-scale vaccine manufacturing capabilities.
• Asia Pacific is expected to exhibit the fastest growth, due to the expansion of pharmaceutical manufacturing, increased investment in biotechnology, and growth in life sciences research.
• Peptones derived from animals continue to be the largest source segment due to their established use in industrial fermentation and microbiological culture media.
• The Cell Culture segment continues to be the leading application segment owing to the increasing production of biologics, vaccine development and research in regenerative medicine.
• Powder is preferred for better storage stability, transportation convenience, and longer shelf life.
• Growing demand for microbial fermentation and precision biotechnology continues to create new opportunities for peptone manufacturers.
• Growing acceptance of animal-free and plant-based peptones supports product innovation and regulatory compliance across biopharmaceutical applications.

Research Scope & Methodology

This report analyzes the Global Peptone Market by evaluating product innovation, raw material trends, application developments, competitive dynamics, manufacturing technologies, and regional market performance from 2025 through 2036. The study deals with the utilization of peptone in pharmaceutical, biotechnology, microbiology, food processing, and industrial fermentation industries.

The research methodology comprises primary interviews with peptone manufacturers, biotechnology companies, pharmaceutical companies, contract development and manufacturing organizations (CDMOs), research laboratories, distributors, and industry experts. Secondary research includes peer-reviewed publications from public health organizations, regulatory agencies, biotechnology associations, government bodies and scientific research organizations published after 2022. The market estimate is based on biologics production, manufacturing of vaccines, microbial culture media demand, fermentation activities, and expenditure on life sciences research. Forecast models include macroeconomic indicators, pharmaceutical investment, biotechnology innovation, regulatory developments and global healthcare spending. Triangulating data from manufacturers, research institutions, end users and distributors, strong forecasting accuracy is attained.

Key Market Segments

By Source:

Plants

Animal

Microbial

By Application:

Cell Culture

Pharmaceuticals

Food & Beverages

Biotechnology & Fermentation

Other Applications

By Form:

Powder

Granules

Liquid

By Product:

Casein Peptone

Meat Peptone

Gelatin Peptone

Yeast Peptone

Other Products

Key Market Players

Merck KGaA

Kerry Inc.

Thermo Fisher Scientific Inc.

Tatua Co-operative Dairy Company Limited

Biotechnica

Organotechnie

Procelys by Lesaffre

Solabia Group

Hardy Diagnostics

Nu-Tek BioScience, LLC.

Industry Trends

• The increase in production of biologics, vaccines, monoclonal antibodies and cell-based therapies is creating demand for high quality peptones used in culture media and bioprocessing.
• Biotechnology companies are increasingly turning to plant-derived and animal-free peptones to improve process consistency, reduce contamination risks and meet evolving regulatory requirements.
• Rising investments in microbial fermentation for pharmaceuticals, industrial enzymes, probiotics and specialty chemicals is driving growth of the use of peptones as nutrient-rich fermentation media.
• Pharmaceutical manufacturers still put emphasis on high-purity raw materials for the improvement of reproducibility and product quality in large-scale biomanufacturing processes.
• The preferred commercial form of powdered peptones is still the best for storage stability, easier transportation and longer shelf life.
• Improvements in enzymatic hydrolysis methods are improving peptone quality, nutrient profile and batch-to-batch uniformity for use in biotechnological applications.
• The demand for laboratory-grade peptones is being driven by the increasing cell culture and microbiological research activities undertaken by academic research institutions and contract research organizations.
• With growing demand for precision fermentation, cultured proteins and synthetic biology, new commercial opportunities for specialized peptone formulations are opening up.
• Manufacturers are also putting money into traceability, quality assurance and sustainable sourcing of raw materials to improve product reliability and regulatory compliance.
• Ongoing collaborations between biotech companies, life science suppliers and pharma manufacturers are driving innovation in advanced culture media ingredients.

Market Determinants

• Expanding Biopharmaceutical and Vaccine Manufacturing: The rapid growth of biologics, vaccines, monoclonal antibodies, and recombinant protein production is a major driver of the peptone market. Peptones serve as critical nutrient sources in cell culture media and microbial fermentation, supporting the growth of microorganisms and mammalian cells used in pharmaceutical manufacturing. According to the World Health Organization (WHO, 2024), continued investments in vaccine production and advanced biologics manufacturing are strengthening global demand for high-quality culture media ingredients.
• Rising Demand for Cell Culture and Biotechnology Research: Growing research activities in biotechnology, regenerative medicine, synthetic biology, and life sciences are increasing the consumption of peptones in laboratory and commercial applications. Academic institutions, contract research organizations (CROs), and biotechnology companies rely on high-performance culture media to improve research efficiency and production consistency.
• Growth in Industrial Fermentation Applications: Peptones are widely utilized in industrial fermentation for producing enzymes, probiotics, amino acids, antibiotics, and specialty chemicals. Expanding applications of microbial fermentation across pharmaceuticals, food processing, and biotechnology industries are driving sustained demand for nutritionally balanced peptone formulations capable of supporting efficient microbial growth.
• Increasing Adoption of Animal-Free and Plant-Based Peptones: Biopharmaceutical manufacturers are increasingly adopting plant-derived and microbial peptones to reduce contamination risks, improve regulatory compliance, and enhance batch consistency. Growing interest in animal-free production systems is encouraging manufacturers to develop innovative plant-based culture media ingredients for advanced biotechnology applications.
• High Production Costs and Raw Material Price Volatility: Peptone manufacturing requires high-quality protein sources, specialized hydrolysis technologies, and stringent purification processes. Fluctuating prices of dairy proteins, meat derivatives, plant proteins, and microbial feedstocks can increase production costs and affect manufacturer profitability.
• Stringent Regulatory and Quality Requirements: Peptones used in pharmaceutical and biotechnology applications must comply with rigorous quality standards relating to purity, traceability, sterility, and batch consistency. Meeting diverse international regulatory requirements increases manufacturing complexity, validation costs, and time-to-market for new products.

Opportunity Mapping Based on Market Trends

• Expansion of Cell and Gene Therapy Manufacturing: Growing commercialization of cell therapies, gene therapies, regenerative medicine, and personalized biologics is creating significant opportunities for premium peptone formulations designed for advanced cell culture systems. According to the WHO (2024), continued innovation in advanced therapeutics is expected to increase demand for high-performance culture media components.
• Rising Adoption of Precision Fermentation: The rapid expansion of precision fermentation for alternative proteins, specialty enzymes, sustainable chemicals, and bio-based ingredients is creating new opportunities for peptone manufacturers. Nutrient-rich fermentation media capable of supporting high-yield microbial production are becoming increasingly important across emerging biotechnology industries.
• Development of Animal-Free and Sustainable Products: Growing regulatory emphasis on animal-free manufacturing and sustainable biotechnology is encouraging investment in plant-derived, microbial, and recombinant peptones. Companies developing environmentally responsible and highly reproducible culture media ingredients are expected to benefit from increasing global demand.
• Growth Across Emerging Biotechnology Markets: Expanding pharmaceutical manufacturing, biotechnology research infrastructure, and vaccine production capacity across Asia Pacific, Latin America, the Middle East, and Africa are creating favorable conditions for market expansion. Increasing public and private investments in life sciences and healthcare innovation are expected to generate substantial long-term opportunities for peptone manufacturers throughout emerging economies.

Value-Creating Segments and Growth Pockets

Animal-derived peptones dominate the market through established performance in microbial culture media

By Source, the market is segmented into Plant, Animal, and Microbial. Of these, animal-derived peptones will account for an estimated 49.3% of the global peptone market in 2025 - a significant share. Their leadership is attributed to their rich nutritional makeup, balanced amino acid profile, and proven effectiveness in supporting microbial growth, vaccine development, and industrial fermentation. Animal-derived peptones, especially casein and meat peptones, continue to be widely used for pharmaceutical production, microbiological testing, and biotechnology applications due to their high reliability and established regulatory acceptance. According to the World Health Organization (WHO, 2024), the ongoing growth in the production of biologics and vaccines is fueling the demand for high-quality culture media ingredients.

The Microbial segment is projected to grow at the highest CAGR of 6.4% during the forecast period. The rapid adoption of microbial-derived peptones in the pharmaceutical and biotechnology industries is fueled by rising demand for animal-free culture media, progress in microbial biotechnology and increasing regulatory support for sustainable production inputs.

Cell culture remains the largest application while biotechnology and fermentation accelerate future growth

Based on the Application segment, the Cell Culture segment held the highest market share of around 38.7% in 2025. Growing production of vaccines, monoclonal antibodies, recombinant proteins and advanced biologics continues to fuel the demand for nutrient-rich peptones to support consistent cell growth and high bioprocess productivity. Increasing investments in regenerative medicine and cell-based research are further enhancing the segment's market leadership.

The Biotechnology & Fermentation segment is expected to register the highest growth rate during the forecast period. Growing precision fermentation, industrial biotechnology, enzyme manufacturing, probiotics and cultured protein production are driving strong demand for specialized peptone formulations that can support high efficiency microbial cultivation and scalable industrial bioprocesses.

Animal-free bioprocessing creates the strongest long-term value opportunity

The biggest opportunity for value creation over the long term is the development of animal-free, plant-derived and microbially-derived peptones for next-generation biopharmaceutical manufacturing and precision fermentation. Manufacturers are responding to the increased regulatory emphasis on traceability, contamination control, sustainability, and reproducibility by developing culture media ingredients that are consistent, chemically defined and sustainable. Companies that invest in advanced hydrolysis technologies, recombinant protein platforms and novel fermentation-based peptone production are likely to capture long-term growth opportunities across the global peptone market.

Regional Market Assessment

North America dominates the market through advanced biopharmaceutical manufacturing and biotechnology leadership

North America held the largest share in the global peptone market in 2025, accounting for 39.1% of the revenue. The country has a highly advanced biopharmaceutical industry, extensive biotech research, a strong vaccine manufacturing industry and major investments in life sciences. The United States is driving regional demand with its significant production of biologics, monoclonal antibodies, cell therapies and microbial fermentation products. Ongoing investment in biomedical research and biotechnology innovation is driving demand for high-quality culture media ingredients, such as peptones, according to the National Institutes of Health (NIH, 2024). The presence of major pharmaceutical manufacturers, contract development and manufacturing organisations (CDMOs), and leading life science suppliers further reinforces the market leadership of North America.

Europe maintains a strong market position through pharmaceutical innovation and regulatory excellence

The pharmaceutical industry is mature, the biotechnology infrastructure is advanced and the quality standards are strict for the manufacturing of biologics, which supports Europe as a large regional market. Germany, France, the United Kingdom, Switzerland and Denmark continue to invest in vaccine production, industrial fermentation and cell culture technologies. The demand for high quality cell culture media components across the region is being driven by increasing development of advanced therapy medicinal products (ATMPs) and biologics, according to the European Medicines Agency (EMA, 2024). Increasing adoption of sustainable and animal-free peptones is also supporting market expansion.

Asia Pacific records the fastest growth through expanding pharmaceutical production and biotechnology investments

Asia Pacific is expected to witness the highest growth during the forecast period with an estimated CAGR of 6.2% from 2026 to 2036. Market growth is driven by rapid expansion of pharmaceutical manufacturing, increasing biotechnology research, rising vaccine production capacity and growing investments in life sciences across China, India, Japan, South Korea and Singapore. The World Health Organization (WHO, 2024) reports that the rising healthcare infrastructure and the expansion of biologics manufacturing capacities throughout Asia are boosting the demand for advanced culture media ingredients in the region. Market development is further aided by government support for biotechnology innovation and precision medicine.

LAMEA presents emerging opportunities through healthcare expansion and biotechnology development

The LAMEA region is expected to witness a steady growth during the forecast period, owing to the continuous government investments in pharmaceutical manufacturing, biotechnology infrastructure and healthcare modernization. Latin America is boosting its capacity for vaccine production and microbiological research, and Middle Eastern countries are investing in biotechnology and pharmaceutical self-reliance. Through public health initiatives and international collaborations, Africa is scaling up laboratory research, vaccine manufacturing, and diagnostic capabilities. The World Health Organization (WHO, 2024) projects that sustained investments in healthcare resilience and regional biomanufacturing capabilities will drive the continued demand for peptones in emerging markets across LAMEA.

Recent Developments

• June 2025: Thermo Fisher Scientific Inc. expanded its bioproduction portfolio by introducing advanced cell culture media components and high-performance peptone solutions designed to improve biologics manufacturing efficiency and process consistency.
• April 2025: Merck KGaA strengthened its cell culture business through investments in next-generation culture media technologies, including animal-origin-free nutrient formulations supporting biopharmaceutical manufacturing and advanced therapeutic development.
• October 2024: Procelys by Lesaffre expanded its fermentation-derived peptone portfolio with specialized nutrient solutions developed for microbial fermentation, vaccine production, and industrial biotechnology applications.
• August 2024: Solabia Group enhanced its biotechnology ingredient portfolio by investing in innovative peptone production technologies focused on improving nutrient consistency, traceability, and sustainability for life sciences and pharmaceutical applications.

Critical Business Questions Addressed

What is the current and projected size of the global peptone market?

The global peptone market was valued at USD 300.00 million in 2025 and is projected to reach USD 522.10 million by 2036, growing at a CAGR of 5.1% during the forecast period.

Which factors are driving market growth?

The market is driven by expanding biopharmaceutical manufacturing, increasing vaccine production, rising demand for cell culture media, growth in industrial fermentation, expanding biotechnology research, and increasing adoption of animal-free and plant-derived culture media ingredients.

Which source segment dominates the market?

Animal-derived Peptones hold the largest market share due to their balanced nutritional profile, proven effectiveness in microbial cultivation, broad regulatory acceptance, and extensive use in pharmaceutical manufacturing, vaccine production, and industrial fermentation.

Which application segments are expected to generate the greatest value?

Cell Culture remains the largest application segment owing to increasing production of biologics, vaccines, and monoclonal antibodies, while Biotechnology & Fermentation is expected to record the fastest growth due to rapid expansion of precision fermentation, industrial biotechnology, enzyme manufacturing, and cultured protein production.

Which regions offer the strongest future growth opportunities?

North America currently leads the global market through advanced biopharmaceutical manufacturing, biotechnology innovation, and extensive life sciences research. Asia Pacific is projected to record the fastest growth due to expanding pharmaceutical production, increasing biotechnology investments, and rising vaccine manufacturing capacity, while Europe continues to generate significant demand through pharmaceutical innovation and stringent quality standards. Emerging opportunities are also expanding across the LAMEA region through healthcare modernization, regional biomanufacturing initiatives, and biotechnology infrastructure development.

Beyond the Forecast

• The peptone market is expected to evolve toward next-generation cell culture nutrition, where highly defined, animal-origin-free, and application-specific peptone formulations improve reproducibility, regulatory compliance, and manufacturing efficiency across advanced bioprocesses.
• Advancements in precision fermentation, recombinant protein technologies, enzymatic hydrolysis, microbial-derived nutrients, and chemically defined media development will enable manufacturers to produce more consistent, sustainable, and high-performance peptones for biologics, vaccines, cell therapies, and industrial biotechnology.
• As global biologics production, precision medicine, regenerative therapies, synthetic biology, and sustainable biomanufacturing continue expanding, companies investing in innovative culture media ingredients, scalable fermentation technologies, and traceable raw material sourcing will be well positioned to achieve sustained long-term growth in the global peptone market.

Table of Contents

Chapter 1. Global Peptone Market Report Scope & Methodology

• 1.1. Market Definition
• 1.2. Market Segmentation
• 1.3. Research Assumption
  • 1.3.1. Inclusion & Exclusion
  • 1.3.2. Limitations
• 1.4. Research Objective
• 1.5. Research Methodology
  • 1.5.1. Forecast Model
  • 1.5.2. Desk Research
  • 1.5.3. Top Down and Bottom-Up Approach
• 1.6. Research Attributes
• 1.7. Years Considered for the Study

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Strategic Insights
• 2.3. Top Findings
• 2.4. CEO/CXO Standpoint
• 2.5. ESG Analysis

Chapter 3. Global Peptone Market Forces Analysis

• 3.1. Market Forces Shaping The Global Peptone Market (2025-2036)
• 3.2. Drivers
  • 3.2.1. Growing Demand for Biopharmaceutical and Vaccine Production
  • 3.2.2. Expansion of Pharmaceutical and Biotechnology Research
  • 3.2.3. Increasing Adoption in Industrial Fermentation Processes
  • 3.2.4. Growing Demand for Microbiological Testing and Diagnostics
• 3.3. Restraints
  • 3.3.1. Fluctuating Availability and Cost of Raw Materials
  • 3.3.2. Stringent Regulatory and Quality Compliance Requirements
• 3.4. Opportunities
  • 3.4.1. Growing Demand for Plant-Based and Animal-Free Peptones
  • 3.4.2. Expansion of Biomanufacturing in Emerging Economies

Chapter 4. Global Peptone Industry Analysis

• 4.1. Porter's 5 Forces Model
• 4.2. Porter's 5 Force Forecast Model (2025-2036)
• 4.3. PESTEL Analysis
• 4.4. Macroeconomic Industry Trends
  • 4.4.1. Parent Market Trends
  • 4.4.2. GDP Trends & Forecasts
• 4.5. Value Chain Analysis
• 4.6. Top Investment Trends & Forecasts
• 4.7. Top Winning Strategies (2025)
• 4.8. Market Share Analysis (2025)
• 4.9. Pricing Analysis
• 4.10. Investment & Funding Scenario
• 4.11. Impact of Geopolitical & Trade Policy Volatility on the Market

Chapter 5. AI Adoption Trends and Market Influence

• 5.1. AI Readiness Index
• 5.2. Key Emerging Technologies
• 5.3. Patent Analysis
• 5.4. Top Case Studies

Chapter 6. Global Peptone Market Size & Forecasts by Source 2025-2036

• 6.1. Market Overview
• 6.2. Global Peptone Market Performance - Potential Analysis (2025)
• 6.3. Plants
  • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 6.3.2. Market size analysis, by region, 2025-2036
• 6.4. Animal
  • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 6.4.2. Market size analysis, by region, 2025-2036
• 6.5. Microbial
  • 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 6.5.2. Market size analysis, by region, 2025-2036

Chapter 7. Global Peptone Market Size & Forecasts by Application 2025-2036

• 7.1. Market Overview
• 7.2. Global Peptone Market Performance - Potential Analysis (2025)
• 7.3. Cell Culture
  • 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 7.3.2. Market size analysis, by region, 2025-2036
• 7.4. Pharmaceuticals
  • 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 7.4.2. Market size analysis, by region, 2025-2036
• 7.5. Food & Beverages
  • 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 7.5.2. Market size analysis, by region, 2025-2036
• 7.6. Biotechnology & Fermentation
• 7.7. Other Applications
  • 7.7.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 7.7.2. Market size analysis, by region, 2025-2036

Chapter 8. Global Peptone Market Size & Forecasts by Form 2025-2036

• 8.1. Market Overview
• 8.2. Global Peptone Market Performance - Potential Analysis (2025)
• 8.3. Powder
  • 8.3.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 8.3.2. Market size analysis, by region, 2025-2036
• 8.4. Granules
  • 8.4.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 8.4.2. Market size analysis, by region, 2025-2036
• 8.5. Liquid
  • 8.5.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 8.5.2. Market size analysis, by region, 2025-2036

Chapter 9. Global Peptone Market Size & Forecasts by Product 2025-2036

• 9.1. Market Overview
• 9.2. Global Peptone Market Performance - Potential Analysis (2025)
• 9.3. Casein Peptone
  • 9.3.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 9.3.2. Market size analysis, by region, 2025-2036
• 9.4. Meat Peptone
  • 9.4.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 9.4.2. Market size analysis, by region, 2025-2036
• 9.5. Gelatin Peptone
  • 9.5.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 9.5.2. Market size analysis, by region, 2025-2036
• 9.6. Yeast Peptone
  • 9.6.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 9.6.2. Market size analysis, by region, 2025-2036
• 9.7. Other Products
  • 9.7.1. Top Countries Breakdown Estimates & Forecasts, 2025-2036
  • 9.7.2. Market size analysis, by region, 2025-2036

Chapter 10. Global Peptone Market Size & Forecasts by Region 2025-2036

• 10.1. Growth Peptone Market, Regional Market Snapshot
• 10.2. Top Leading & Emerging Countries
• 10.3. North America Peptone Market
  • 10.3.1. U.S. Peptone Market
    • 10.3.1.1. Source breakdown size & forecasts, 2025-2036
    • 10.3.1.2. Application breakdown size & forecasts, 2025-2036
    • 10.3.1.3. Form breakdown size & forecasts, 2025-2036
    • 10.3.1.4. Product breakdown size & forecasts, 2025-2036
  • 10.3.2. Canada Peptone Market
• 10.4. Europe Peptone Market
  • 10.4.1. UK Peptone Market
  • 10.4.2. Germany Peptone Market
  • 10.4.3. France Peptone Market
  • 10.4.4. Spain Peptone Market
  • 10.4.5. Italy Peptone Market
  • 10.4.6. Rest of Europe Peptone Market
• 10.5. Asia Pacific Peptone Market
  • 10.5.1. China Peptone Market
  • 10.5.2. India Peptone Market
  • 10.5.3. Japan Peptone Market
  • 10.5.4. Australia Peptone Market
  • 10.5.5. South Korea Peptone Market
  • 10.5.6. Rest of APAC Peptone Market
• 10.6. Latin America Peptone Market
  • 10.6.1. Brazil Peptone Market
  • 10.6.2. Mexico Peptone Market
• 10.7. Middle East and Africa Peptone Market
  • 10.7.1. UAE Peptone Market
  • 10.7.2. Saudi Arabia (KSA) Peptone Market
  • 10.7.3. South Africa Peptone Market

Chapter 11. Competitive Intelligence

• 11.1. Top Market Strategies
• 11.2. Merck KGaA
  • 11.2.1. Company Overview
  • 11.2.2. Key Executives
  • 11.2.3. Company Snapshot
  • 11.2.4. Financial Performance (Subject to Data Availability)
  • 11.2.5. Product/Services Port
  • 11.2.6. Recent Development
  • 11.2.7. Market Strategies
  • 11.2.8. SWOT Analysis
• 11.3. Kerry Inc.
• 11.4. Thermo Fisher Scientific Inc.
• 11.5. Tatua Co-operative Dairy Company Limited
• 11.6. Biotechnica
• 11.7. Organotechnie
• 11.8. Procelys by Lesaffre
• 11.9. Solabia Group
• 11.10. Hardy Diagnostics
• 11.11. Nu-Tek BioScience, LLC.